TriSalus Life Sciences (TLSIW) Leases (2022 - 2026)

TriSalus Life Sciences (TLSIW) has 5 years of Leases data on file, last reported at $830000.0 in Q1 2026.

• For the quarter ending Q1 2026, Leases fell 27.0% year-over-year to $830000.0; the trailing twelve-month figure through Mar 2026 stood at $830000.0 (down 27.0% YoY), and the FY2025 full-year result was $861000.0, down 28.84% from the prior year.
• Leases for Q1 2026 stood at $830000.0, down from $861000.0 in the prior quarter.
• Across five years, Leases topped out at $1.4 million in Q3 2024 and bottomed at $830000.0 in Q1 2026.
• The 5-year median for Leases is $1.2 million (2023), against an average of $1.1 million.
• The widest annual swing landed in 2024, when Leases climbed 13.98%; it then sank 37.63% in 2025.
• A 5-year view of Leases shows it stood at $1.4 million in 2022, then fell by 14.63% to $1.2 million in 2023, then increased by 2.63% to $1.2 million in 2024, then retreated by 28.84% to $861000.0 in 2025, then dropped by 3.6% to $830000.0 in 2026.
• The last three Leases figures came in at $830000.0 (Q1 2026), $861000.0 (Q4 2025), and $890000.0 (Q3 2025), per Business Quant data.

Peer Comparison